Home › Opioid Overdose › West Virginia › Morgantown
Opioid Overdose clinical trials in Morgantown, WV
4 studies for Opioid Overdose are looking for participants at sites in and around Morgantown (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Evaluation of Tirzepatide as an Adjunct to Buprenorphine for the Treatment of Opioid Use Disorder
RecruitingPhase 2
- Healthy Minds/Chestnut Ridge, Morgantown
Exablate for LIFU Neuromodulation in Patients With Opioid Use Disorder (OUD) and/or Other Substance Use Disorders (SUDs)
RecruitingHealthy volunteers welcome
- West Virginia University: Rockefeller Neuroscience Institute, Morgantown
LIFU for Treatment for Refractory Opioid Use Disorder
Recruiting
- WVU Rockefeller Neuroscience Institute, Morgantown
Continuum of Care in Hospitalized Patients With Opioid/Stimulant Use Disorder and Infectious Complications From Drug Use
Recruiting
- West Virginia University, Morgantown
About Opioid Overdose
Opioid overdose leads to slowing or stopping of breathing and sometimes death. You can take steps to help prevent an overdose, and respond to one with naloxone.
More about Opioid Overdose on MedlinePlus
Opioid Overdose trials in other cities
- Baltimore, MD18 studies
- New Haven, CT18 studies
- Philadelphia, PA15 studies
- Boston, MA12 studies
- New York City, NY12 studies
- Birmingham, AL7 studies
- Salt Lake City, UT7 studies
- Pittsburgh, PA7 studies
- Providence, RI6 studies
- San Francisco, CA6 studies
- Charleston, SC6 studies
- Indianapolis, IN5 studies
Other studies in Morgantown
- Breast Cancer10 studies
- Non-Small Cell Lung Cancer10 studies
- Ovarian Cancer10 studies
- Cardiovascular Disease8 studies
- Lung Cancer6 studies
- Metastatic Cancer6 studies
- Cancer (all types)6 studies
- Heart Failure6 studies
- Colon Cancer5 studies
- Melanoma5 studies
- Migraine5 studies
- Obesity4 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.